Baker Bros. Advisors »

Alpine Immune Sciences shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Alpine Immune Sciences (ALPN) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Alpine Immune Sciences

Tip: Access up to 7 years of quarterly data

All positions including Alpine Immune Sciences held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alpine Immune Sciences by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.2M 82k 39.64

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeiGene Sponsored Adr (BGNE)
ACADIA Pharmaceuticals (ACAD)
Madrigal Pharmaceuticals (MDGL)
Rhythm Pharmaceuticals (RYTM)
Revolution Medicines (RVMD)
Kymera Therapeutics (KYMR)
Abcellera Biologics (ABCL)
Bicycle Therapeutics Sponsored Ads (BCYC)
Edgewise Therapeutics (EWTX)
Immunocore Holdings Ads (IMCR)
Kodiak Sciences (KOD)
Roivant Sciences SHS (ROIV)
Replimune Group (REPL)
Denali Therapeutics (DNLI)

View all positions for Baker Bros. Advisors

Top funds holding Alpine Immune Sciences

Decheng Capital
BlackRock
Frazier Life Sciences Management
T. Rowe Price Associates
Vanguard Group
Cormorant Asset Management
OrbiMed Advisors
Lynx1 Capital Management
Paradigm Biocapital Advisors
Darwin Global Management
Commodore Capital
Octagon Capital Advisors
Avidity Partners Management
Dr. Jeffrey R. Jay, M.D.
Franklin Resources

View all funds holding Alpine Immune Sciences